Inhaled epoprostenol and inhaled nitric oxide use for COVID positive patients with ARDS

Last Updated: February 11, 2021 by Michael Lazar
(Originally posted on: February 11, 2021
– Here are the policy and PowerPoint which contains education on inhaled epoprostenol and inhaled nitric oxide use for COVID positive patients with ARDS.  
– The PowerPoint has audio embedded in it.
– The policy will be “live” on 2/17/21.

Leave a Reply

Your email address will not be published. Required fields are marked *